logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Matthew J. Frigault

Harvard University
H指数:45
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tumor-infiltrating lymphocyte therapy generated from melanoma brain metastasis: Proof-of-concept for CNS-derived cellular immunotherapy
Neuro-Oncology
IF13.4
2025-12-150
PRE
Eric P Grewal; Samuel J Steuart; Baolin Liu; Hongyan Xie; Derek N Effiom; Aleigha R Lawless; Tatyana Sharova; Caroline Zielinski; Howard L Kaufman; Brian V Nahed; Maria Martinez-Lage; Sonia Cohen; Matthew J Frigault; Nancy Wang; Elizabeth R Gerstner; Alexandra Haugh; Russell W Jenkins; Nir Hacohen; Moshe Sade-Feldman; William T Curry; Donald P Lawrence; Genevieve M Boland; Bryan D Choi
Recommendations for Defining Chimeric Antigen Receptor T-Cell (CAR T) Dose-Limiting Toxicities (DLTs) for Future Early-Phase CAR T Therapy Studies

关于未来早期CAR T疗法研究中定义嵌合抗原受体T细胞（CAR T）剂量限制性毒性（DLTs）的建议

Transplantation and Cellular Therapy
IF4.4
2025-11-070
PRE
Frederick L. Locke; Sarah Nikiforow; Matthew J. Frigault; David G. Maloney; Marco Davila; David B. Miklos; Yi Lin; Judy Vong; Nirav N. Shah; Sattva S. Neelapu; John Welch; Eric Ng; Caron Jacobson; Marcela V. Maus
Clinical Presentation, Management and Outcome of Tumor inflammation-associated neurotoxicity (TIAN) in CNS lymphoma treated with CD19-CAR T-cell therapy

肿瘤炎症相关神经毒性（TIAN）在经CD19-CAR T细胞疗法治疗的CNS淋巴瘤中的临床表现、管理与转归

NEURO-ONCOLOGY
IF13.4
2025-11-010
OAAI
Kaulen, Leon D.; Martinez-Lage, Maria; Abramson, Jeremy S.; Karschnia, Philipp; Doubrovinskaia, Sofia; Shankar, Ganesh; Choi, Bryan; Ramundo, Christopher M.; Ehret, Felix; Barnes, Jeffrey A.; El-Jawahri, Areej; Hochberg, Ephraim P.; Johnson, P. Connor; Soumerai, Jacob D.; Plotkin, Scott; Batchelor, Tracy; Wick, Wolfgang; Maus, Marcela, V; Chen, Yi-Bin; Frigault, Matthew J.; Dietrich, Jorg
NASCENT CLINICAL EXPERIENCE WITH RADIOTHERAPEUTIC MANAGEMENT OF MELANOMA BRAIN METASTASES IN PATIENTS TREATED WITH TUMOR-INFILTRATING LYMPHOCYTE (TIL) THERAPY

早期临床经验：肿瘤浸润淋巴细胞（TIL）疗法治疗患者中，放射性疗法管理黑色素瘤脑转移的应用

NEURO-ONCOLOGY
IF13.4
2025-11-010
OAAI
Choudhury, Abrar; Lawrence, Donald; Frigault, Matthew; Cohen, Sonia; Mooradian, Meghan; Sullivan, Ryan; Khandekar, Melin; Oh, Kevin; Brastianos, Priscilla; Shih, Helen; Haugh, Alexandra; Marciscano, Ariel
Mesothelin is a surface antigen present on human meningioma and can be effectively targeted by CAR T-cells

间皮素是一种存在于人类脑膜瘤表面的抗原，并且可以被CAR T细胞有效靶向。

NEURO-ONCOLOGY
IF13.4
2025-11-010
OAAI
Ramapriyan, Rishab; Barker, Fred; Richardson, Leland; Sun, Jing; Vandecandelaere, Gust; Shim, Jane; De Vlaminck, Guillaume; Gaffey, Matthew; Grewal, Eric; Tazhibi, Masih; Morshedy, Kourosh; Aref, Amir; Batool, Syeda; Guo, Xiaopeng; Ijad, Nazanin; Balaj, Leonora; Wakimoto, Hiroaki; Martinez-Lage, Maria; Frigault, Matthew; Leick, Mark; Bernstock, Joshua; Bi, Wenya Linda; Carter, Bob; Chiocca, E. Antonio; Dietrich, Jorg; Gerstner, Elizabeth; Boland, Genevieve; Nahed, Brian; Plotkin, Scott; Jenkins, Russell; Brastianos, Priscilla; Curry, William; Maus, Marcela; Choi, Bryan
Erratum to <[Transplant Cell Ther. 2023 Jul;29(7):438.e1-438.e16. Epub 2023 Mar 9]>

勘误：《免疫效应细胞相关噬血细胞性淋巴组织细胞增多症样综合征》\[Transplant Cell Ther. 2023 Jul;29(7):438.e1-438.e16. Epub 2023 Mar 9\]

Transplantation and Cellular Therapy
IF4.4
2025-10-300
OAAI
Melissa R. Hines; Tristan E. Knight; Kevin O. McNerney; Mark B. Leick; Tania Jain; Sairah Ahmed; Matthew J. Frigault; Joshua A. Hill; Michael D. Jain; William T. Johnson; Yi Lin; Kris M. Mahadeo; Gabriela M. Maron; Rebecca A. Marsh; Sattva S. Neelapu; Sarah Nikiforow; Amanda K. Ombrello; Nirav N. Shah; Aimee C. Talleur; David Turicek; Anant Vatsayan; Sandy W. Wong; Marcela V. Maus; Krishna V. Komanduri; Nancy Berliner; Jan-Inge Henter; Miguel-Angel Perales; Noelle V. Frey; David T. Teachey; Matthew J. Frank; Nirali N. Shah
CRS or ICANS Are Rare Beyond 2 Weeks After Lisocabtagene Maraleucel Infusion: Data From Clinical Trials and the Real-World Setting

CRS或ICANS在lisocabtagene maraleucel输注2周后较为罕见：来自临床试验和真实世界的数据

Transplantation and Cellular Therapy
IF4.4
2025-10-240
PRE
Bradley D. Hunter; Matthew Lunning; Mazyar Shadman; Sairah Ahmed; Jeremy S. Abramson; Miguel-Angel Perales; Nausheen Ahmed; Abu-Sayeef Mirza; Iris Isufi; Matthew J. Frigault; Jennifer L. Crombie; David B. Miklos; Alberto Vasconcelos; Alessandro Crotta; David Bernasconi; Debasmita Roy; Eric Bleickardt; Marcelo C. Pasquini; Manali Kamdar
Cardiovascular complications and their association with short- and long-term outcomes in patients with multiple myeloma undergoing chimeric antigen receptor T-cell therapy

心血管并发症及其与接受嵌合抗原受体T细胞疗法的多发性骨髓瘤患者短期和长期预后的关联

British Journal of Haematology
IF3.8
2025-10-190
PRE
Osnat Itzhaki Ben Zadok; Panagiotis Simitsis; Caron Jacobson; Omar Nadeem; Matthew J. Frigault; Noopur Raje; Caitlyn Duffy; Patrick Costello; Jamie Dela Cruz; Andrew Looka; Anju Nohria
B NASCENT CLINICAL EXPERIENCE WITH RADIOTHERAPEUTIC MANAGEMENT OF MELANOMA BRAIN METASTASES IN PATIENTS TREATED WITH TUMOR-INFILTRATING LYMPHOCYTE (TIL) THERAPY

B 新的临床经验：使用放射治疗管理接受肿瘤浸润淋巴细胞（TIL）疗法患者的黑色素瘤脑转移

NEURO-ONCOLOGY
IF13.4
2025-10-010
OAAI
Choudhury, A.; Lawrence, D. P.; Frigault, M. J.; Cohen, S.; Mooradian, M. J.; Sullivan, R. J.; Khandekar, M. J.; Oh, K. S.; Brastianos, P.; Shih, H. A.; Haugh, A. M.; Marciscano, A. E.
Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinoma

I期ADP-A2AFP TCR T细胞疗法在晚期肝细胞癌或胃肝样腺癌患者中的临床试验

Journal of Hepatology
IF33
2025-08-120
PREAI
Tim Meyer; Richard S. Finn; Mitesh Borad; Amit Mahipal; Julien Edeline; Roch Houot; Petr F. Hausner; Antoine Hollebecque; Lipika Goyal; Matthew Frigault; Thomas R. Jeffry Evans; Kit Man Wong; Benjamin R. Tan; Emmanuel Mitry; Debashis Sarker; Lynn Feun; Bassel El-Rayes; Fiona Thistlethwaite; Ahmed Kaseb; Olatunji Alese
Safe and effective addition of ruxolitinib to graft-versus-host prophylaxis in older adults undergoing reduced-intensity allogeneic hematopoietic cell transplantation

在老年患者接受减低强度异基因造血细胞移植时，将ruxolitinib安全有效地添加到移植物抗宿主病预防方案中。

Transplantation and Cellular Therapy
IF4.4
2025-08-110
PRE
Christof C. Smith; Jooho Chung; Areej El-Jawahri; Matthew J. Frigault; Steven McAfee; Richard A. Newcomb; Paul V. O’Donnell; Thomas R. Spitzer; Peter Westervelt; Yi-Bin Chen; Zachariah DeFilipp
Clinical presentation, management and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell Therapy

TIAN的临床表现、管理及CD19-CAR T细胞治疗下在中枢神经系统淋巴瘤中的结局

Blood
IF23.1
2025-07-170
PRE
Leon D. Kaulen; Maria Martinez-Lage; Jeremy S. Abramson; Philipp Karschnia; Sofia Doubrovinskaia; Ganesh M. Shankar; Bryan D. Choi; Christopher M. Ramundo; Felix Ehret; Jeffrey A. Barnes; Areej El-Jawahri; Ephraim P. Hochberg; P. Connor Johnson; Jacob D. Soumerai; Scott R. Plotkin; Tracy T. Batchelor; Wolfgang Wick; Marcela V. Maus; Yi-Bin Chen; Matthew J. Frigault; Jorg Dietrich
Mesothelin is a surface antigen present on human meningioma and can be effectively targeted by CAR T-cells

Ramapriyan, R.; Barker, F.G., 2nd; Richardson, L.G.; Sun, J.; Vandecandelaere, G.; Shim, J.M.; De Vlaminck, G.; Gaffey, M.; Grewal, E.P.; Tazhibi, M.; et al. 纤维蛋白是存在于人类脑膜瘤表面的抗原，并且可以被CAR T细胞有效靶向。Neuro-Oncology 2025, noaf155. [Google Scholar] [CrossRef]

Neuro-Oncology
IF13.4
2025-07-015
PRE
Ramapriyan, Rishab; Barker, Fred G.; Richardson, Leland G.; Sun, Jing; Vandecandelaere, Gust; Shim, Jane M.; De Vlaminck, Guillaume; Gaffey, Matthew; Grewal, Eric P.; Tazhibi, Masih; Morshedy, Kourosh; Aref, Amir R.; Batool, Syeda M.; Guo, Xiaopeng; Ijad, Nazanin; Balaj, Leonora; Wakimoto, Hiroaki; Martinez-Lage, Maria; Frigault, Matthew J.; Leick, Mark B.; Bernstock, Joshua D.; Bi, Wenya Linda; Carter, Bob S.; Chiocca, E. Antonio; Dietrich, Jorg; Gerstner, Elizabeth R.; Boland, Genevieve M.; Nahed, Brian, V; Plotkin, Scott R.; Jenkins, Russell W.; Brastianos, Priscilla K.; Curry, William T.; Maus, Marcela, V; Choi, Bryan D.
5-5-5 ABRT (Dose of 5 Gy per Fraction for up to 5 Fractions Over 5 Weeks Adaptive Bridging Radiation Therapy)—Artificial Intelligence Enters the CAR (-T) (Chimeric Antigen Receptor-T) in Relapsed/Refractory Large B Cell Lymphoma

5-5-5 ABRT（5周内进行最多5次分割，每次分割剂量为5 Gy的自适应桥接放疗）——人工智能进入CAR(-T）（嵌合抗原受体-T）治疗复发/难治性大B细胞淋巴瘤领域

international journal of radiation oncology biology physics
IF0
2025-04-030
PRE
Hazim S. Ababneh; Andrea K. Ng; Joshua Wan; Tyler Walburn; Lin Zhu; Mislav Bobić; Patrick Connor Johnson; Jeremy Bredtfeld; Jonathan Leeman; Jacob Soumerai; Jeremy S. Abramson; Jeffrey Barnes; Ronald Takvorian; Matthew J. Frigault; Jennifer Pursley; Chirayu G. Patel

研究方向

暂未获取到该数据
M
Marcela V. Maus
H 指数:84论文数:512被引数:3.2万
M
Mark B. Leick
H 指数:22论文数:164被引数:3,654
C
Caron A. Jacobson
H 指数:59论文数:580被引数:2.3万
A
Areej El‐Jawahri
H 指数:62论文数:716被引数:1.5万
P
P. Connor Johnson
H 指数:22论文数:161被引数:1,740
J
Jeremy S. Abramson
H 指数:69论文数:511被引数:1.9万
Y
Yi‐Bin Chen
H 指数:58论文数:451被引数:1.5万
B
Bryan D. Choi
H 指数:36论文数:336被引数:6,596
J
Jörg Dietrich
H 指数:51论文数:398被引数:9,788
N
Noopur Raje
H 指数:102论文数:1,025被引数:4.4万